FOXC2 Vital To Epithelial-Mesenchymal Transition In BC...

Options

http://www.medicalnewstoday.com/releases/256377.php

FOXC2 Vital To Epithelial-Mesenchymal Transition In Breast Cancer; FDA-Approved Drug Blocks Its Effect In Preclinical Studies

Categories